Metabulin
PrivateCompany Overview
Metabulin is a biotechnology company developing an ultra-stable, monomeric insulin analog designed to improve pharmacokinetics and simplify diabetes management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
insulin formulationmonomeric insulincold-chain logisticsdiabetes careprotein engineeringbiotechdrug discoveryinsulin analogroom temperature insulinpharma supply chaintherapeuticsbio-pharmaglucose control
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metabulin Comparables
Compare Metabulin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermalin Diabetes | 86% | |
| Invictus Therapeutics | 86% | |
| Lamark Biotech | 83% | |
Metabulin Funding Rounds
Historical fundraising activity
Metabulin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Metabulin's valuation, stock price, and market status.
See something wrong or outdated?